SLS earnings date and last-quarter result: next report 2026-08-11, last quarter beat, P/E -52.91. Updated 2026-07-23.
SELLAS Life Sciences Group (SLS) Research Hub
SELLAS Life Sciences Group (SLS) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 11.34 USD (-1.73%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -52.91, market cap 2.24B. This hub links to the full technical, earnings and options research available for SLS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 11.34 USD (-1.73%) |
| 52-week range | 7.46 USD – 15.88 USD |
| Trend regime | Range |
| 14-day RSI | 50 (Neutral) |
| Trailing P/E | -52.91 |
| Market cap | 2.24B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for SLS
Covered Call on SLS: how it works, illustrative setup around the real 11.34 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SLS: how it works, illustrative setup around the real 11.34 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SLS: how it works, illustrative setup around the real 11.34 USD price, max profit/loss, breakeven and when to use it. Educational.
SLS technical analysis: range, last 11.34 USD, RSI 50, 52w range 7.46 USD–15.88 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SLS in?
SELLAS Life Sciences Group (SLS) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is SLS in an uptrend or downtrend?
As of 2026-10-26, SLS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SLS's trailing P/E ratio?
SLS's trailing P/E is -52.91, with a market cap of 2.24B. See the earnings research page for full valuation detail.
When does SLS next report earnings?
SLS is next scheduled to report earnings on 2026-08-11.